ORKA
Oruka Therapeutics Inc.
Company Overview
| Mkt Cap | $1.03B | Price | $28.17 |
| Volume | 341.64K | Change | +0.21% |
| P/E Ratio | -192.5 | Open | $28.24 |
| Revenue | -- | Prev Close | $28.11 |
| Net Income | $-5.3M | 52W Range | $5.49 - $29.46 |
| Div Yield | N/A | Target | $43.63 |
| Overall | 75 | Value | 60 |
| Quality | -- | Technical | 91 |
No chart data available
Stock Overview
Updated DailyOruka Therapeutics Inc. (ORKA) is a leading diversified company in the business industry, currently trading at $28.17 with a market capitalization of $1.03 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ORKA with a volume of 342K shares. The stock opened up 0.46% from yesterday's close of $28.11. Current analyst estimates project earnings of $-2.12 per share for this year, with next year targeting $-2.46.
ORKA demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for ORKA include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 54.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:49 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORKA | $28.17 | +0.2% | 341.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |